Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Bianca van Diermen-Hidle"'
Autor:
Melinda Lillesand, Vebjørn Kvikstad, Ok Målfrid Mangrud, Einar Gudlaugsson, Bianca van Diermen-Hidle, Ivar Skaland, Jan P A Baak, Emiel A M Janssen
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0233676 (2020)
In urothelial cell type non-muscle invasive urinary bladder carcinoma, TNM stage and WHO grade are widely used to classify patients into low and high‑risk groups for prognostic and therapeutic decision-making. However, stage and grade reproducibili
Externí odkaz:
https://doaj.org/article/328286ebd5f8424b85e7acc0c09fadd4
Autor:
Nina Gran Egeland, Marie Austdal, Bianca van Diermen-Hidle, Emma Rewcastle, Einar G Gudlaugsson, Jan P A Baak, Ivar Skaland, Emiel A M Janssen, Kristin Jonsdottir
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0212527 (2019)
Protein expression of Myristoylated alanine-rich C kinase substrate like-1 (MARCKSL1) has been identified as a prognostic factor in lymph-node negative (LN-) breast cancer patients. We aim to validate MARCKSL1 protein expression as a prognostic marke
Externí odkaz:
https://doaj.org/article/f72e39ff4ef04171a355054783b1e98b
Autor:
Birgit Engesæter, Bianca van Diermen Hidle, Mona Hansen, Pia Moltu, Kjersti Mangseth Staby, Siri Borchgrevink-Persen, Olav K. Vintermyr, Stefan Lönnberg, Mari Nygård, Emiel A. M. Janssen, Philip E. Castle, Irene Kraus Christiansen
Publikováno v:
BMC Infectious Diseases, Vol 16, Iss 1, Pp 1-8 (2016)
Abstract Background Human papillomavirus (HPV) testing as primary screening for cervical cancer is currently being implemented in Norway in a randomized controlled fashion, involving three laboratories. As part of the quality assurance programme of t
Externí odkaz:
https://doaj.org/article/78758775caa04652966a7fe80862053e
Autor:
Ivar Skaland, Emiel A. M. Janssen, Ok Målfrid Mangrud, Jan P. A. Baak, Einar Gudlaugsson, Vebjørn Kvikstad, Bianca van Diermen-Hidle, Melinda Lillesand
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0233676 (2020)
PLOS ONE
PLoS ONE
PLOS ONE
PLoS ONE
In urothelial cell type non-muscle invasive urinary bladder carcinoma, TNM stage and WHO grade are widely used to classify patients into low and high‑risk groups for prognostic and therapeutic decision-making. However, stage and grade reproducibili
Autor:
Marie Austdal, Bianca van Diermen-Hidle, Einar Gudlaugsson, Ivar Skaland, Emiel A. M. Janssen, Jan P. A. Baak, Kristin Jonsdottir, Emma Rewcastle, Nina Egeland
Publikováno v:
14:e0212527
PLOS ONE
PLoS ONE, Vol 14, Iss 3, p e0212527 (2019)
PLoS ONE
PLOS ONE
PLoS ONE, Vol 14, Iss 3, p e0212527 (2019)
PLoS ONE
Protein expression of Myristoylated alanine-rich C kinase substrate like-1 (MARCKSL1) has been identified as a prognostic factor in lymph-node negative (LN-) breast cancer patients. We aim to validate MARCKSL1 protein expression as a prognostic marke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f5f9f5d6baebcd3b78300746babfc5b
https://hdl.handle.net/11250/3046357
https://hdl.handle.net/11250/3046357
Autor:
Vebjørn Kvikstad, Ivar Skaland, Ok Målfrid Mangrud, Emiel A. M. Janssen, Jan P. A. Baak, Einar Gudlaugsson, Bianca van Diermen-Hidle, Melinda Lillesand
Publikováno v:
Clinical Cancer Research. 26:PR03-PR03
Urothelial carcinoma is the most common type of carcinoma of the urinary bladder in the Western world. Currently TNM stage and WHO grade are the most important histopathologic parameters to classify patients into low- and high-risk groups and to deci
Autor:
Einar Gudlaugsson, Bianca van Diermen Hidle, Arnold-Jan Kruse, Jan P. A. Baak, Emiel A. M. Janssen, Ivar Skaland, Irene T Øvestad, Ane Cecilie Munk, Bent Fiane, Kjell Løvslett
Publikováno v:
Gynecologic Oncology, 127(3), 489-494. Elsevier Science
Cervical intraepithelial neoplasia grades 2-3 (CIN2-3) are usually treated by cone excision, although only 30% progress to cancer and 6-50% regress spontaneously. Biomarkers predicting CIN2-3 regression would be of great clinical value and could redu
Autor:
Stefan Lönnberg, Emiel A. M. Janssen, Irene Kraus Christiansen, Pia Moltu, Bianca van Diermen Hidle, Mona Hansen, Siri Borchgrevink-Persen, Birgit Engesæter, Kjersti M. Staby, Philip E. Castle, Olav Karsten Vintermyr, Mari Nygård
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 16, Iss 1, Pp 1-8 (2016)
BMC Infectious Diseases, Vol 16, Iss 1, Pp 1-8 (2016)
Background Human papillomavirus (HPV) testing as primary screening for cervical cancer is currently being implemented in Norway in a randomized controlled fashion, involving three laboratories. As part of the quality assurance programme of the implem
Autor:
Bent Fiane, Emiel A. M. Janssen, Ivar Skaland, Kjell Løvslett, Arnold J. Kruse, Jan P. A. Baak, Irene T Øvestad, Bianca van Diermen-Hidle, Einar Gudlaugsson, Ane Cecilie Munk
Publikováno v:
Infectious Agents and Cancer, Vol 7, Iss 1, p 30 (2012)
Infectious Agents and Cancer
Infectious Agents and Cancer
Background The major cause of cervical intraepithelial neoplasia (CIN) is persistent infection with human papillomavirus (HPV). Most CIN grade 2 and 3 lesions are treated with cone excision, although a substantial proportion (6-50%) of CIN2-3 lesions